Abstract
Bone marrow acid phosphatase was determined by radioimmunoassay and enzymatic analysis in 95 patients with benign prostatic hypertrophy, 50 patients with disseminated prostatic carcinoma and 36 patients with non-prostatic malignancy. The results indicate superior specificity of the radioimmunoassay. A brief review of the topic and the clinical implications are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 442-446 |
Number of pages | 5 |
Journal | Unknown Journal |
Volume | 121 |
Issue number | 4 |
DOIs | |
State | Published - 1979 |
Externally published | Yes |
ASJC Scopus subject areas
- Urology